Edwards Lifesciences Corp (NYSE:EW)
| 218.96 Delayed Data As of May 22 |  +0.455 / +0.21%Today’s Change | 154.52 Today|||52-Week Range 247.64 | -6.14% Year-to-Date |
Latest EW News | Press Releases
No recent news for Edwards Lifesciences Corp.
Today’s Trading
| Previous close | 218.50 |
| Today’s open | 218.53 |
| Day’s range | 215.39 - 219.04 |
| Volume | 730,965 |
| Average volume (3 months) | 1,591,839 |
| Market cap | $45.2B |
Data as of 4:17pm ET, 05/22/2020
Growth & Valuation
| Earnings growth (last year) | +45.68% |
| Earnings growth (this year) | -11.72% |
| Earnings growth (next 5 years) | +13.45% |
| Revenue growth (last year) | +16.79% |
| P/E ratio | 41.9 |
| Price/Sales | 11.39 |
| Price/Book | 11.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ISRGIntuitive Surgical | +17.10 | +3.13% |
| SYKStryker Corp | -0.91 | -0.49% |
| SNNSmith & Nephew PLC | -0.29 | -0.70% |
| STESteris plc | +1.27 | +0.82% |
Data as of 4:49pm ET, 05/22/2020
Financials
| Next reporting date | July 28, 2020 |
| EPS forecast (this quarter) | $0.55 |
| Annual revenue (last year) | $4.3B |
| Annual profit (last year) | $1.0B |
| Net profit margin | 24.08% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
